OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Monoclonal antibody levels and protection from COVID-19
Eva Stadler, Martin Burgess, Timothy E. Schlub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Eva Stadler, Martin Burgess, Timothy E. Schlub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Showing 10 citing articles:
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 89
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 89
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 100991-100991
Open Access | Times Cited: 32
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 100991-100991
Open Access | Times Cited: 32
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
Dean Follmann, Meagan P. O’Brien, Jonathan Fintzi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Dean Follmann, Meagan P. O’Brien, Jonathan Fintzi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
Eva Stadler, Khai Li Chai, Timothy E. Schlub, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 11, pp. e883-e892
Open Access | Times Cited: 22
Eva Stadler, Khai Li Chai, Timothy E. Schlub, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 11, pp. e883-e892
Open Access | Times Cited: 22
A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance
Daniele Focosi
Viruses (2023) Vol. 15, Iss. 5, pp. 1048-1048
Open Access | Times Cited: 9
Daniele Focosi
Viruses (2023) Vol. 15, Iss. 5, pp. 1048-1048
Open Access | Times Cited: 9
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Monoclonal Antibody Therapies Against SARS-CoV-2: Promises and Realities
Daniele Focosi
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Daniele Focosi
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
What type of vaccine immunity controls breakthrough COVID?
Stephen J. Kent, Miles P. Davenport
Vaccine Insights (2023) Vol. 02, Iss. 08, pp. 317-321
Open Access
Stephen J. Kent, Miles P. Davenport
Vaccine Insights (2023) Vol. 02, Iss. 08, pp. 317-321
Open Access
